- Home
- RDNW vs FBRX Comparison
RDNW vs FBRX Comparison
Compare RDNW & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDNW
- FBRX
- Stock Information
- Founded
- RDNW 2013
- FBRX N/A
- Country
- RDNW United States
- FBRX United States
- Employees
- RDNW N/A
- FBRX N/A
- Industry
- RDNW EDP Services
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- RDNW Technology
- FBRX Health Care
- Exchange
- RDNW Nasdaq
- FBRX Nasdaq
- Market Cap
- RDNW 147.3M
- FBRX 154.5M
- IPO Year
- RDNW N/A
- FBRX N/A
- Fundamental
- Price
- RDNW $3.83
- FBRX $10.92
- Analyst Decision
- RDNW
- FBRX Strong Buy
- Analyst Count
- RDNW 0
- FBRX 3
- Target Price
- RDNW N/A
- FBRX $68.00
- AVG Volume (30 Days)
- RDNW 2.1M
- FBRX 63.8K
- Earning Date
- RDNW 08-11-2025
- FBRX 08-14-2025
- Dividend Yield
- RDNW N/A
- FBRX N/A
- EPS Growth
- RDNW N/A
- FBRX N/A
- EPS
- RDNW N/A
- FBRX N/A
- Revenue
- RDNW $1,109,200,000.00
- FBRX N/A
- Revenue This Year
- RDNW N/A
- FBRX N/A
- Revenue Next Year
- RDNW $7.73
- FBRX N/A
- P/E Ratio
- RDNW N/A
- FBRX N/A
- Revenue Growth
- RDNW N/A
- FBRX N/A
- 52 Week Low
- RDNW $1.46
- FBRX $4.11
- 52 Week High
- RDNW $7.06
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- RDNW N/A
- FBRX 48.35
- Support Level
- RDNW N/A
- FBRX $10.65
- Resistance Level
- RDNW N/A
- FBRX $11.57
- Average True Range (ATR)
- RDNW 0.00
- FBRX 0.93
- MACD
- RDNW 0.00
- FBRX -0.04
- Stochastic Oscillator
- RDNW 0.00
- FBRX 19.22
About RDNW RideNow Group Inc. Class B Common Stock
RideNow Group Inc is a USA-based online retailer that allows consumers and dealers both to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).